- Home
- ADPT vs THR Comparison
ADPT vs THR Comparison
Compare ADPT & THR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ADPT | THR |
|---|---|---|
| Founded | 2009 | 1954 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Industrial Machinery/Components |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 1.3B |
| IPO Year | 2019 | 2011 |
Fundamental Metrics
Financial Performance| Metric | ADPT | THR |
|---|---|---|
| Price | $15.43 | $40.22 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 10 | 0 |
| Target Price | ★ $16.60 | N/A |
| AVG Volume (30 Days) | ★ 3.0M | 380.8K |
| Earning Date | 11-05-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 36.04 |
| EPS | N/A | ★ 1.75 |
| Revenue | $252,754,000.00 | ★ $509,054,000.00 |
| Revenue This Year | $50.81 | $4.87 |
| Revenue Next Year | $1.17 | $4.78 |
| P/E Ratio | ★ N/A | $22.93 |
| Revenue Growth | ★ 42.57 | 3.08 |
| 52 Week Low | $5.81 | $23.05 |
| 52 Week High | $20.76 | $41.20 |
Technical Indicators
Market Signals| Indicator | ADPT | THR |
|---|---|---|
| Relative Strength Index (RSI) | 44.33 | 74.62 |
| Support Level | $14.58 | $38.01 |
| Resistance Level | $16.26 | $41.20 |
| Average True Range (ATR) | 1.13 | 1.47 |
| MACD | -0.36 | 0.30 |
| Stochastic Oscillator | 13.75 | 88.05 |
Price Performance
Historical ComparisonAbout ADPT Adaptive Biotechnologies Corporation
Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).
About THR Thermon Group Holdings Inc.
Thermon Group Holdings Inc is a United States-based company that provides engineered industrial process heating solutions for process industries. It offers a full suite of products (heating units, electrode and gas-fired boilers, heating cables, industrial heating blankets and related products, temporary power solutions and tubing bundles), services (engineering, installation and maintenance services) and software (design optimization and wireless and network control systems) required to deliver comprehensive solutions to some of the world's Large and most complex projects. Its products and services include a wide range of electric heat tracing cables, steam heating solutions, controls, monitoring and software, instrumentation, project services, industrial heating and filtration solutions.